Neurological disorders and immunosuppression in kidney transplant patients. Preliminary study
PDF (Spanish)
PubMed

Supplementary Files

HTML (Spanish)

Keywords

Neurological Alterations
Kidney Transplant
Immunosuppression
Immunosupression Time
Cyclosporin
Tacrolimus

Abstract

Background: Neurological disorders in kidney transplant patients may be related to several factors, including high toxicity to the use of immunosuppressive drugs.

Objective: To find out whether there was association between neurological complications and immunosuppression in a sample of patients who received renal transplantation.

Methods: Cross-sectional study in which 121 renal transplant patients participated, of which 22 (18%) had neurological disorders, χ2 was used to analyze the relation between neurological disorders and comorbidity such as diabetes mellitus and hypertension and time of immunosuppressant use. A significance level of p <0.05 was accepted for all determinations

Results: Of the subjects studied, 13 were male (59%) and nine female (41%). The mean age of the patients included in the study was 33 ± 12 years. 59% of neurological disorders occurred between six months and five years after patients had received the transplant. Neurological alterations found were: tremor (7.4%), dizziness (4.1%), peripheral neuropathy (3.3%), headache (2.4%), and decreased strength (0.8%).

Conclusion: No statistically significant association was found between neurological disorders and immunosuppressant use, or between them and the duration of immunosuppression.

PDF (Spanish)
PubMed

References

Patchell RA. Neurological complications of organ transplantation. Ann Neurol. 1994;36(5):688-703. doi: 10.1002/ana.410360503

Martínez AJ. The neuropathology of organ transplantation: comparison and contrast in 500 patients. Pathol Res Pract. 1998;194(7):473-86.

Jindal RM, Ryan JJ, Sajjad I, Murthy MH, Baines LS. Kidney transplantation and gender disparity. Am J Nephrol. 2005;25(5):474-483. doi: 10.1159/000087920

Jost L, Nogues M, Dávalos M, Turín M, Manes F, Leiguarda R. Complicaciones neurológicas del trasplante renal. Medicina (B Aires) 2000;60:161-164.

Secretaría de Salud. Guía de práctica clínica. Terapia inmunosupresora en el trasplante renal, México: Secretaría de Salud; 2008. Disponible en: http://cvsp.cucs.udg.mx/guias/TODAS/IMSS_112_08_TERAPIA_INMUNOSUPRESORA_TRASPLANTE_RENAL/IMSS_112_08_EyR.pdf

Gatault P, Bertrand D, Büchler M, Colosio C, Hurault de Ligny B, Weestel PF, et al. Eight-year results of the Spiesser study, a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantation. Transpl Int. 2016;29(1):41-50. doi: 10.1111/tri.12656

Fernández-Ramos JA, López-Lasoa E, Ordónez-Díaz MD, Camino-Leóna R, Ibarra-de la Rosa I, Frías-Pérez MA, et al. Complicaciones neurológicas en trasplantados de órgano sólido. An Pediatr (Barc). 2013;78(3):149-156. doi:10.1016/j.anpedi.2012.08.001

Soria V. Trastornos neuropsiquiátricos asociados al uso de ciclosporina en pacientes trasplantados. Psiq Biol. 2002;9(4):158-163.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright (c) 2016 Revista Alergia México

Downloads

Download data is not yet available.